Recombinant Coronavirus antigens (Coronavirus Protein , COVID-19 antigens, or COVID-19 protein) Nucleocapsid(N protein), Spike(S protein), RBD, Envelope (E protein)
COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly.
GeneMedi produces kinds of recombinant Coronavirus antigens (Coronavirus Protein , COVID-19 antigens, or COVID-19 protein, also called 2019 nCoV antigens) as shown below:
Recombinant Nucleocapsid(N protein), Spike protein (S protein,S1+S2 ECD), Spike protein (S1 protein), spike RBD protein, Envelope (E protein), 3C-like Proteinase.
Coronavirus related recombinant proteins (Coronavirus proteins, COVID-19 proteins, 2019 nCoV proteins) were expressed in kinds of expression systems: E.coli, mammalian (human cells, HEK293) and baculovirus-insect cells.
All the recombinant proteins of coronavirus 2019 (COVID-19) are suitable immunogens for in functional ELISA, lateral-flow tests, and other immunoassays.
GeneMedi has submitted a preprints review about COVID-19 and 2019-nCoV.
Click here for the full-text reading:
An Insight of comparison between COVID-19 (2019-nCoV disease) and SARS in pathology and pathogenesis
Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro -- A comparison of PCR vs Immunoassay vs Crispr-Based test
In the mission of helping global scientists for the development of diagnosis and drug against 2019 nCoV(SARS2 coronavirus), GeneMedi scientists will keep moving.
Recombinant 2019 nCoV (SARS2 coronavirus) Antigens reagents